Quick Answer
Nuvation Bio Inc. reported Total Assets of $594.82 million for fiscal year 2025.
Nuvation Bio Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $594.82M | +10.0% |
| 2024 | $540.63M | -13.0% |
| 2023 | $621.48M | -7.5% |
| 2022 | $672.14M | -13.4% |
| 2021 | $776.15M | +249.9% |
| 2020 | $221.79M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $601.56M | +5.2% | -7.1% |
| June 30, 2025 | $647.23M | +8.8% | +31.4% |
| March 31, 2025 | $492.49M | -19.7% | -8.9% |
| December 31, 2024 | $540.63M | -13.0% | -5.4% |
| September 30, 2024 | $571.58M | -9.4% | -3.9% |
| June 30, 2024 | $594.80M | -7.3% | -3.0% |
| March 31, 2024 | $613.12M | -6.7% | -1.3% |
| December 31, 2023 | $621.48M | -7.5% | -1.5% |
- Nuvation Bio Inc. showed an increase of +10.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Nuvation Bio Inc.’s total assets has grown by 168.2% (from $221.79 million to $594.82 million).
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: